Key Financial Data Of Group

Perseus Proteomics Inc. - Filing #7296856

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
Key financial data of group
Business results of group
Net sales
59,390,000 JPY
100,402,000 JPY
50,937,000 JPY
Ordinary profit (loss)
-427,243,000 JPY
-879,380,000 JPY
-429,084,000 JPY
Net assets
1,838,254,000 JPY
1,398,344,000 JPY
1,783,942,000 JPY
Total assets
2,191,325,000 JPY
1,693,810,000 JPY
1,989,786,000 JPY
Basic earnings (loss) per share
-35.90
-93.69
-53.87
Diluted earnings per share
Equity-to-asset ratio
0.8027 xbrli:pure
0.7818 xbrli:pure
0.8703 xbrli:pure
Net cash provided by (used in) operating activities
-312,460,000 JPY
-833,898,000 JPY
-464,745,000 JPY
Net cash provided by (used in) investing activities
-52,089,000 JPY
-150,343,000 JPY
-129,402,000 JPY
Net cash provided by (used in) financing activities
919,892,000 JPY
63,943,000 JPY
JPY
Cash and cash equivalents
2,086,449,000 JPY
1,541,419,000 JPY
1,866,008,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.